PetMed Express
PETS
162 hedge funds and large institutions have $286M invested in PetMed Express in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 48 reducing their positions, and 32 closing their positions.
28% more call options, than puts
Call options by funds: $7.39M | Put options by funds: $5.77M
19% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 48
1.46% less ownership
Funds ownership: 77.98% → 76.52% (-1.5%)
8% less funds holding
Funds holding: 176 → 162 (-14)
11% less capital invested
Capital invested by funds: $320M → $286M (-$34.4M)
31% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.04M |
| 2 |
SG Americas Securities
New York
|
+$3.72M |
| 3 |
BlackRock
New York
|
+$3.38M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.13M |
| 5 |
Bank of New York Mellon
New York
|
+$2.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$2.12M |
| 2 |
Millennium Management
New York
|
-$1.9M |
| 3 |
Morgan Stanley
New York
|
-$1.81M |
| 4 |
NIMC
Nierenberg Investment Management Company
Camas,
Washington
|
-$1.58M |
| 5 |
CCM
Chimera Capital Management
New York
|
-$1.46M |
PETS Hedge Fund Activity: Q4 2022 in Review
162 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in PetMed Express (PETS) for Q4 2022, worth a combined $286M — down 11% from $320M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of PETS and 22 opened new positions — a net loss of 10 holders — while 48 trimmed existing stakes and 57 added.
The largest buyer was UBS Group, adding an estimated $5.04M. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $2.12M sold.
- 162 institutional investors held PetMed Express (PETS) as of Q4 2022, down from 176 in Q3 2022.
- Funds reported $286M of PetMed Express stock for Q4 2022, down 11% quarter-over-quarter.
- 22 funds opened new PetMed Express positions in Q4 2022 and 32 closed out, a net change of -10 holders.
- The largest PetMed Express buyer in Q4 2022 was UBS Group, an estimated $5.04M added.
- The largest PetMed Express seller in Q4 2022 was D.E. Shaw & Co, an estimated $2.12M sold.
Based on aggregated 13F filings for Q4 2022.